Tenaya Therapeutics (TNYA) Research & Development (2020 - 2026)
Tenaya Therapeutics (TNYA) posted Research & Development of $14.87 million for Q3 2026, down 3.2% from $15.36 million a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Tenaya Therapeutics (TNYA) Research & Development (2020 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Research & Development at Tenaya Therapeutics was $61.11 million, down 15.7% year-over-year; for FY2025, it came in at $68.61 million, down 20.9% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 17.1% (FY2020 to FY2025).
- In prior years, Tenaya Therapeutics' Research & Development was $86.74 million in FY2024 (-11.5%), $98.04 million in FY2023 (+3.7%), $94.54 million in FY2022 (+73.8%) and $54.39 million in FY2021 (+74.9%).
- Quarterly Research & Development has run from a low of $14.8 million in Q4 2025 to a high of $26.48 million in Q2 2023 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last 13 quarters, with an average decline of 17.5% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q1 2022, with growth of 151.9%; the weakest was Q1 2026, with a decline of 29.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $16.6 million (Q2 2026), $14.84 million (Q1 2026) and $14.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Tenaya Therapeutics | 90.81 Mn | 24.01 Mn | - | 14.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.87 Mn |
| Jun 30, 2026 | 16.60 Mn |
| Mar 31, 2026 | 14.84 Mn |
| Dec 31, 2025 | 14.80 Mn |
| Sep 30, 2025 | 15.36 Mn |
| Jun 30, 2025 | 17.37 Mn |
| Mar 31, 2025 | 21.08 Mn |
| Dec 31, 2024 | 18.69 Mn |
| Sep 30, 2024 | 20.35 Mn |
| Jun 30, 2024 | 22.65 Mn |
| Mar 31, 2024 | 25.06 Mn |
| Dec 31, 2023 | 22.87 Mn |
| Sep 30, 2023 | 23.09 Mn |
| Jun 30, 2023 | 26.48 Mn |
| Mar 31, 2023 | 25.61 Mn |
| Dec 31, 2022 | 25.75 Mn |
| Sep 30, 2022 | 23.76 Mn |
| Jun 30, 2022 | 20.88 Mn |
| Mar 31, 2022 | 24.16 Mn |
| Dec 31, 2021 | 20.95 Mn |
API Access
Tenaya Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TNYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TNYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TNYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();